戻る
AIM ImmunoTech Inc (AIM)価格
AIM 株価推移チャート
AIM 収入
AIM ImmunoTech Inc
$1.34
0%
$0
終値： Jan 16, 16:00:00 GMT-5
$1.34
0%
$0
プレマーケット： Jan 20, 06:16:56 GMT-5
主要データ
前終値
$1.34
始値
$1.32
当日レンジ
$1.31 - $1.38
52週レンジ
$1.07 - $36
取引高
131.8K
平均取引高
108.2K
1株当たり利益(TTM)
-24.68
配当利回り
--
時価総額
$3.8M
AIMとは何ですか？
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. The company is headquartered in Ocala, Florida and currently employs 21 full-time employees. The firm is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) and highly selective TLR3 agonist immuno-modulator, which is being developed for globally important cancers, viral diseases and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS). Alferon N Injection is an injectable formulation of natural alpha interferon, which is approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.